Streetbeat News

Products Services

AYRWF

CRLBF

GTBIF

MRMD

TCNNF

The cannabis industry is experiencing significant growth with new store openings and sales milestones ahead of the Benzinga Cannabis Capital Conference in Florida. Illinois' cannabis market continues to expand, with MariMed Inc. opening a new Thrive dispensary. In Florida, Trulieve Cannabis Corp. and Green Thumb Industries Inc. are expanding their retail footprints amid talks of recreational legalization. AYR Wellness Inc. relocated its Tallahassee dispensary, and in New Jersey, C3 Industries Inc. and Holistic Re-Leaf opened new stores. Pennsylvania sees expansion with new dispensaries by PharmaCann Inc. and Cresco Labs Inc.

Portfolio Pulse from Jelena Martinovic

March 19, 2024 | 2:51 pm

BYDDY

NIO

TSLA

XPEV

Tesla Inc (TSLA) announced price adjustments for its Model Y in the US, Europe, and China, aiming to maintain sales momentum amid declining auto gross margins. XPeng Inc (XPEV) and Nio Inc (NIO) are launching more affordable EV brands to compete in a slowing EV market. XPeng's new EVs will be priced between $14,000 and $21,000, targeting a competitive segment with a strategic partnership with Didi. Nio's mass-market brand 'Le Dao' targets families, aiming to boost deliveries. Tesla plans a low-cost EV by end of 2025, facing competition from BYD Company Limited (BYDDY) which recently surpassed Tesla in sales.

Portfolio Pulse from Upwallstreet

March 19, 2024 | 2:51 pm

AUUD

Auddia Inc has received a U.S. patent for a machine learning technology that identifies shifts in audio content. The patent, numbered 11,935,520, marks a significant intellectual property milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 2:44 pm

ALPN

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) exceeded Q4 earnings expectations with a GAAP EPS of 15 cents against an expected loss of 29 cents and sales of $30.853 million versus the anticipated $9.104 million. The company highlighted significant progress in developing povetacicept for IgAN and other diseases, contributing to a 14.6% stock increase to $40.63. Analysts from HC Wainwright & Co., Oppenheimer, and Morgan Stanley subsequently raised their price targets for ALPN.

Portfolio Pulse from Avi Kapoor

March 19, 2024 | 2:35 pm

CVNA

Carvana (NYSE:CVNA) has seen significant options trading activity, with a mix of bullish and bearish sentiments among investors. Analysis of 13 trades shows a nearly even split between bullish (46%) and bearish (53%) expectations. The trades include 7 puts and 6 calls, with a notable price target range from $69.0 to $125.0. The largest trades indicate a diverse sentiment, with both neutral and bearish positions on calls and puts. Carvana, an e-commerce platform for buying and selling used cars, is currently trading at $78.5, down 2.83%, with an RSI suggesting it may be approaching overbought territory. The company's earnings release is anticipated in 44 days.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 2:31 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for March 19th, 2024, provides a trade strategy for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, based on a proprietary formula. It offers detailed bullish and bearish price targets for each asset, emphasizing the importance of monitoring volume and adjusting tactics according to market conditions. The memo also highlights upcoming economic events likely to impact market volatility, including Housing Starts, Building Permits data, and a 20-Year Bond Auction. Additionally, it promotes Market Clubhouse's services and RIPS's live trading streams.

Portfolio Pulse from RIPS

March 19, 2024 | 2:30 pm

TSLA

Tesla shares are trading lower due to a decrease in weekly insurance registrations for its electric vehicles in China. This news comes as broader growth and tech stocks face pressure ahead of the Federal Reserve's upcoming decision.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 2:29 pm

NVDA

In a CNBC interview, Nvidia's CEO revealed that the R&D budget for the Blackwell platform was approximately $10 billion, highlighting the company's significant investment in this new technology.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 2:23 pm

COSM

Cosmos Health Inc. (NASDAQ:COSM) is nearing regulatory approval in the UK for its C-Scrub disinfectant hand soap and has received its first purchase order. The approval from the UK's Health Security Agency will enable distribution across the UK, with plans to supply the National Health Service. C-Scrub is a biocide disinfectant formulated with 4% chlorhexidine gluconate, offering up to 6 hours of antimicrobial action. Cosmos Health is also exploring opportunities in non-EU markets, targeting the global hospital disinfectant market projected to reach $75.6 billion by 2033.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 2:13 pm

CHKP

NVDA

Check Point Software Technologies Ltd. (CHKP) and NVIDIA (NVDA) have announced a collaboration to enhance the security of AI cloud infrastructure. The partnership involves integrating NVIDIA's BlueField DPUs into Check Point's new AI Cloud Protect solution, aimed at preventing threats at both network and host levels. This solution is designed to protect sensitive and private AI workloads against cyber threats, addressing the increasing sophistication of attacks targeting AI, such as backdooring AI models and data exfiltration. The AI Cloud Protect, powered by NVIDIA BlueField 3 DPU and DOCA software, offers robust defense against AI-specific threats, scalable integration, and optimized performance without compromising AI operations.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 2:10 pm